This medication is sold in a few forms: Ozempic (injectable): approved in2017for lowering blood sugar levels in adults with type 2 diabetes, as well as reducing the risk of heart attack, stroke, or death in those with type 2 diabetes and heart disease Rybelsus (tablet): approved in2019as the first and only GLP-1 analog in pill form and indicated to improve blood sugar regulation in adults with type 2 diabetes Wegovy (injectable): approved in2021for weight management Use of Rybelsus and Ozempic for weight loss is considered However, to maintain the weight loss benefits of semaglutide, people need to continue taking it
Most Canadians dont eat enough fibre, yet its one of the most powerful nutrients for improving fullness, blood sugar control, digestive health, and long-term metabolic health
As patients lose weight, many report enhanced mobility, improved sleep quality, and greater ease performing daily activities
Zeisel and Warrier, 2017), and changes in the gut microbiota have marked effects on TMAO levels
Across all treatment arms, the most commonly reported adverse events were gastrointestinal-related